CN1207300A - Medicine for giving up drug - Google Patents

Medicine for giving up drug Download PDF

Info

Publication number
CN1207300A
CN1207300A CN97108170A CN97108170A CN1207300A CN 1207300 A CN1207300 A CN 1207300A CN 97108170 A CN97108170 A CN 97108170A CN 97108170 A CN97108170 A CN 97108170A CN 1207300 A CN1207300 A CN 1207300A
Authority
CN
China
Prior art keywords
radix
rhizoma
group
drug
rhizoma corydalis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN97108170A
Other languages
Chinese (zh)
Other versions
CN1060075C (en
Inventor
尹大良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaceutical Co Ltd Hunan Hyun Xia
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97108170A priority Critical patent/CN1060075C/en
Publication of CN1207300A publication Critical patent/CN1207300A/en
Application granted granted Critical
Publication of CN1060075C publication Critical patent/CN1060075C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A medicine for dropping drug is prepared from 19 Chinese-medicinal materials such as myrobalan, corydalis tube, notopterygium root, dehurian angelica root, centipede, etc., and features quick taking its effect, less by-effect and no addiction.

Description

A kind of anti-additive medicament
The present invention relates to a kind ofly to can be used for quitting drug abuse, the Chinese medicine of withdrawal.
In recent years, drug abuse has become the public hazards that influence people's physical and mental health, harm family, society.At present, the withdrawal method is various both at home and abroad, but also not safely, not effectively, non-addicted ideal addiction-breaking drugs.
Purpose of the present invention aims to provide a kind of rapid-action, and side effect does not gently have the Chinese medicine medicine of addicted detoxification and addiction-removing.
The Chinese medicine of China is the important wealth of the Chinese nation, and the present invention does not contain a kind of anti-additive medicament of any Western medicine and addiction Chinese medicinal ingredients just according to the pharmacology of Chinese medicine and pharmacy.
The present invention includes Fructus Chebulae, Rhizoma Corydalis, Rhizoma Corydalis Decumbentis.It is equal that Rhizoma Corydalis Decumbentis belongs to Papaveraceae, the equal same sex.The Fructus Chebulae belongs to gentleman's the orchid family.
Ratio between Fructus Chebulae, Rhizoma Corydalis, the Rhizoma Corydalis Decumbentis three is 5: 8: 8.
Fructus Chebulae, Rhizoma Corydalis, Rhizoma Corydalis Decumbentis account for 34.0-37.0% of the present invention, by weight.
Except that above-mentioned principal agent, also comprise Rhizoma Et Radix Notopterygii, the Radix Angelicae Dahuricae, crust halberd, Rhizoma Coptidis, Radix Panacis Quinquefolii, Cordyceps, Bombyx Batryticatus, Radix Glycyrrhizae, Rhizoma Zingiberis, Fructus Jujubae, Cortex Cinnamomi, Radix Codonopsis, Radix Changii, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Ganoderma.
More than each component content be: Rhizoma Et Radix Notopterygii 5.0-6.0% Radix Angelicae Dahuricae 5.0-6.0% crust halberd 1.0-2.0% Rhizoma Coptidis 2.0-3.0% Radix Panacis Quinquefolii 2.0-3.0% Cordyceps 1.0-2.0% Bombyx Batryticatus 1.5-2.5% Radix Glycyrrhizae 10-12% Rhizoma Zingiberis 0.5-1.5% Fructus Jujubae 0.8-1.5% Cortex Cinnamomi 1.5-3.0% Radix Codonopsis 4.0-5.0% Radix Changii 5.0-6.0% Radix Angelicae Sinensis 2.5-3.0% Rhizoma Chuanxiong 5.0-6.0% Ganoderma 3.0-4.0%
The present invention is familiar with according to Chinese medical discrimination, the addiction of drugs suction, and the serious disturbed dominant force of becoming homeless of the mind, the body many-side gets muddled, and forms complicated pathogenesis, causes the generation disharmony of nutrient QI with defensive QI, gastrointestinal, function of liver and spleen imbalance, heart kidney extreme misery is not handed over diseases such as deficiency of both QI and blood.With the passing of time then the thin bone of shape is upright, and the complexion clouding has the gesture of disintegrating greatly.Withdrawal symptom should belong in the malicious expectorant and accumulateing, domination of pathogen dificiency in lower-JIAO, QIYINLIANGXU, lack of preservation of spirit.Present invention focuses on to address the above problem.Rhizoma Corydalis Decumbentis, Rhizoma Corydalis, Fructus Chebulae and Semen Papaveris are of the same race to be we's principal agent with merit, and wherein Rhizoma Corydalis Decumbentis, Rhizoma Corydalis are bloodroot.Fructus Chebulae and Pericarpium Papaveris be sour in the mouth all, the astringing intestine to stop diarrhea of all astringing the lung, and the withdrawal of three medicines energy detoxicating is aided with recuperating the superficial defensive system, the body resistance strengthening and constitution consolidating, the warming the meridian blood stasis dispelling has complement each other wonderful.The prosperous then spirit of gas is shaken, and hemapodium then body is filled, so detoxification and addiction-removing is smooth, and no tired hardship.
Embodiments of the invention:
Fructus Chebulae's 255 gram Rhizoma Corydalis 411 gram Rhizoma Corydalis Decumbentiss 411 gram Rhizoma Et Radix Notopterygiis 180 grams
The Radix Angelicae Dahuricae 180 gram crust halberds 60 gram Bombyx Batryticatus 45 gram Radix Glycyrrhizaes 333 grams
Rhizoma Zingiberis 45 gram Fructus Jujubaes 30 gram Rhizoma Coptidis 90 gram Cortex Cinnamomis 90 grams
Radix Codonopsis 150 gram Radix Changiis 150 gram Radix Panacis Quinquefoliis 90 grams
Radix Angelicae Sinensis 120 gram Rhizoma Chuanxiongs 180 gram Cordycepses 60 kairine sesames 120 grams
Be clinical therapeutic efficacy of the present invention below, and compare with buprenorphine simultaneously: being admitted to hospital on August 11st, 1996 voluntarily continuously with Hunan Province narcotic house, the drug rehabilitation patient is an object of study.Therapist is included into buprenorphine treatment group or Chinese drug-treated group of the present invention at random, each each 11 example of group.With the Ninth Heaven is a course of treatment.
Treatment back 1-3 days, two groups drug craving and body reaction are the heaviest.Two groups relatively, and the physical withdrawal reaction is close, and " wanting especially to take drugs, yawn, have a stomach-ache, suffer from abdominal pain " several of Dante group is serious relatively, and difference has significance.The fourth group is total, and to crave for sense stronger than Chinese drug-treated group, and it is obviously lower than fourth group that Chinese drug-treated group was craved for total points on the 3rd day.
Two groups of physical withdrawal reactions in fourth, fifth day are close, craving for of Chinese drug-treated group this moment than a little less than the fourth group, " have a stomach-ache, stomachache, watery nasal discharge, shed tears " several of group is obviously light than the fourth group in the 4th day, " fidgety, easily fly into a rage " of group is obviously light than the fourth group in the 5th day, and craving for than the 4th day of fourth group the 5th day increases to some extent.
From treating the 6th day, the withdrawal symptom and the drug craving of Chinese drug-treated group obviously descend, and the decline of fourth group is not obvious, and the withdrawal symptom total points of Chinese drug-treated group is obviously lower than fourth group to the Ninth Heaven in treatment seven.
Treat " nauseating, regurgitation " transference cure of the 6th, seven day Chinese drug-treated group, Chinese drug-treated group " irritated, easily fly into a rage ", " covering with gooseflesh ", " ache all over the body discomfort ", " sometimes hot and sometimes cold ", " feel uneasy or be difficult to loose " " insomnia " etc. are obviously light than the fourth group, the fourth group to crave for middle group of sense heavy slightly, but total points no difference of science of statistics.
Chart 1 is that two groups of patients crave for situation of change day by day;
Chart 2 is that two groups of patient's physical withdrawals react situation of change day by day.
The drawing explanation: ◆-Ding organizes ■-Chinese drug-treated group
From chart 1,2 as seen, two groups of physical withdrawals reaction, to crave for sense generally equal Along with the passing for the treatment of time is on a declining curve. And show that Chinese drug-treated group is in therapeutic process Physical withdrawal symptom and crave for all light than the fourth group. The physical withdrawal symptom of Chinese drug-treated group always On a declining curve, substantially disappeared by the 9th day, average total points only has 4.6 fens, And the fourth group is not obvious since physical withdrawal symptom decline in the 5th day, and the 9th day average total Divide to also have 14.6 fens, two groups to crave for total points on a declining curve with therapeutic advance.
In the treatment during Chinese drug-treated group withrawal symptom and crave for always all low than fourth group, the result Show that the treatment by Chinese herbs onset is very fast, the course for the treatment of is shorter, and withrawal symptom does not have when the treatment withdrawal The characteristics such as bounce-back.

Claims (3)

1, a kind of anti-additive medicament is characterized in that including Fructus Chebulae, Rhizoma Corydalis, Rhizoma Corydalis Decumbentis, Rhizoma Et Radix Notopterygii, the Radix Angelicae Dahuricae, crust halberd, Rhizoma Coptidis, Radix Panacis Quinquefolii, Cordyceps, Bombyx Batryticatus, Radix Glycyrrhizae, Rhizoma Zingiberis, Fructus Jujubae, Cortex Cinnamomi, Radix Codonopsis, Radix Changii, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Ganoderma.
2, a kind of anti-additive medicament according to claim 1 is characterized in that Fructus Chebulae, Rhizoma Corydalis, Rhizoma Corydalis Decumbentis account for 34.0-37.0% of the present invention, and the ratio between the three is 5: 8: 8, by weight.
3, a kind of anti-additive medicament according to claim 1 and 2 is characterized in that: Rhizoma Et Radix Notopterygii 5.0-6.0% Radix Angelicae Dahuricae 5.0-6.0% clings to halberd 1.0-2.0% Rhizoma Coptidis 2.0-3.0% Radix Panacis Quinquefolii 2.0-3.0% Cordyceps 1.0-2.0% Bombyx Batryticatus 1.5-2.5% Radix Glycyrrhizae 10-12% Rhizoma Zingiberis 0.5-1.5% Fructus Jujubae 0.8-1.5% Cortex Cinnamomi 1.5-3.0% Radix Codonopsis 4.0-5.0% Radix Changii 5.0-6.0% Radix Angelicae Sinensis 2.5-3.0% Rhizoma Chuanxiong 5.0-6.0% Ganoderma 3.0-4.0% by weight
CN97108170A 1997-07-31 1997-07-31 Medicine for giving up drug Expired - Fee Related CN1060075C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97108170A CN1060075C (en) 1997-07-31 1997-07-31 Medicine for giving up drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97108170A CN1060075C (en) 1997-07-31 1997-07-31 Medicine for giving up drug

Publications (2)

Publication Number Publication Date
CN1207300A true CN1207300A (en) 1999-02-10
CN1060075C CN1060075C (en) 2001-01-03

Family

ID=5170191

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97108170A Expired - Fee Related CN1060075C (en) 1997-07-31 1997-07-31 Medicine for giving up drug

Country Status (1)

Country Link
CN (1) CN1060075C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1069056C (en) * 1999-03-29 2001-08-01 苏月秋 Pure Chinese herb medicine for stopping drugs
CN1090026C (en) * 1999-11-11 2002-09-04 中国科学院西北高原生物研究所 Novel medicine for stopping narcotic taking and preparation process thereof
CN107348135A (en) * 2017-07-19 2017-11-17 安徽宏飞户外用品科技有限公司 A kind of additive in the imitated baits for being easy to fish for

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1092315A (en) * 1993-03-18 1994-09-21 孙先知 A kind of external dressing ointment for wound
CN1098638A (en) * 1993-08-07 1995-02-15 章贤君 A kind of detoxicating mixture

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1069056C (en) * 1999-03-29 2001-08-01 苏月秋 Pure Chinese herb medicine for stopping drugs
CN1090026C (en) * 1999-11-11 2002-09-04 中国科学院西北高原生物研究所 Novel medicine for stopping narcotic taking and preparation process thereof
CN107348135A (en) * 2017-07-19 2017-11-17 安徽宏飞户外用品科技有限公司 A kind of additive in the imitated baits for being easy to fish for

Also Published As

Publication number Publication date
CN1060075C (en) 2001-01-03

Similar Documents

Publication Publication Date Title
CN100998843A (en) Medicinal composition for treating cholecystitis
CN1047090C (en) Plaster for curing cough with dyspnea
CN1390585A (en) Chinese medicine for detoxication purpose and its preparing process
CN1895547A (en) Medicine for treating diabetes and its preparation
CN101391056B (en) Medicine for treating aplastic anemia
CN1814245A (en) Chinese medicine remedy for treating cervical vertebra disease
CN1044682C (en) Prescription of Chinese medicine for removing opium poison from human body
CN1124856C (en) Pill for treating hemiplegia
CN1060075C (en) Medicine for giving up drug
CN1309401C (en) Herb medicine used for giving-up drug
CN1772245A (en) Snake medicinal wine for health care massage and its application
CN101708230B (en) Anti-drug medicine and preparation method thereof
CN101632831B (en) Traditional Chinese medicine medicated wine for treating waist and leg pains
CN1435227A (en) Medicament for treating lumbar and cervical vertebra pain
CN1087945C (en) Quick action traditional Chinese medicinal prepn. for giving-up drug
CN1294918A (en) Drug refraining medicine and its proportioning method
CN1050759C (en) Medicinal composite for hysteromyoma and preparing method
CN1057695C (en) Herbal medicine for giving up drug
CN1139391C (en) Chinese patent medicine for dropping off drug
CN1118293C (en) Medicine for quickly dropping drug
CN1084210C (en) Health mask for curing and preventing typhoid
CN101444601A (en) Liquid medicine for treating rheumatoid diseases
CN1343517A (en) Medicine for treating dermatopathy and its preparing process
CN1078641A (en) A kind of drug rehabilitation Chinese patent medicine
CN1234395C (en) Medicinal tea of infused in boiling water and its production method

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: HUNAN XUANXIA PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: YIN DALIANG

Effective date: 20031210

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20031210

Address after: 410006 Hunan province Changsha hi tech Industrial Development Zone, valley base of Oak Park D1 Building 2 floor

Patentee after: Pharmaceutical Co., Ltd. Hunan Hyun Xia

Address before: 410007, No. 28, Xinjian West Road, Yuhua Pavilion, Hunan, Changsha

Patentee before: Yin Daliang

PP01 Preservation of patent right

Effective date of registration: 20090814

Pledge (preservation): Preservation

PD01 Discharge of preservation of patent

Date of cancellation: 20100814

Granted publication date: 20010103

PP01 Preservation of patent right

Effective date of registration: 20100814

Granted publication date: 20010103

PD01 Discharge of preservation of patent

Date of cancellation: 20110214

Granted publication date: 20010103

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20010103

Termination date: 20130731